However, it should be noted that a recent study showed that as the liver disease worsens to NASH and cirrhosis, there could be a change in the insulin signaling in the liver from resistance to sensitivity [39]. This evidence concerns the gene INS and metabolic dysfunction-associated steatohepatitis.